Molecular genotyping of papillary thyroid carcinoma follicular variant according to its histological subtypes (encapsulated vs infiltrative) reveals distinct BRAF and RAS mutation patterns

Modern Pathology

Volumn 23, Issue 9, 2010, Pages 1191-1200

  Rivera, Michael ^a   Ricarte Filho, Julio ^a   Knauf, Jeff ^a   Shaha, Ashok ^a   Tuttle, Michael ^a   Fagin, James A ^a   Ghossein, Ronald A ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; PARAFFIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RAS PROTEIN; TRANSCRIPTION FACTOR PAX8;

ADULT; AKT1 GENE; ARTICLE; CANCER GENETICS; CANCER INFILTRATION; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL ARTICLE; FEMALE; GENE MUTATION; GENE REARRANGEMENT; GENETIC VARIABILITY; GENOTYPE; HISTOLOGY; HRAS GENE; HUMAN; HUMAN TISSUE; KRAS GENE; LOBECTOMY; MALE; MASS SPECTROMETRY; METASTASIS; MOLECULAR TYPING; NRAS GENE; ONCOGENE; PIK3CA GENE; PRIORITY JOURNAL; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY;

ADENOCARCINOMA, PAPILLARY; ADULT; AGED; FEMALE; GENES, RAS; GENOTYPE; HUMANS; MALE; MASS SPECTROMETRY; MIDDLE AGED; MUTATION; PROTO-ONCOGENE PROTEINS B-RAF; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THYROID NEOPLASMS;

EID: 77956280558     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2010.112     Document Type: Article

References (25)

1. Rosai J, Carcangiu ML, Delellis RA. Tumors of the thyroid gland In: Rosai J, Sobin LH (eds). Atlas of Tumor Pathology, Vol.5. Armed Forces Institute of Pathology: New York, 1992, pp 161-182.
2. Liu J, Singh B, Tallini G, et al. Follicular variant of papillary thyroid carcinoma: a clinicopathologic study of a problematic entity. Cancer 2006;107:1255-1264.
3. Lloyd RV, Erickson LA, Casey MB, et al. Observer variation in the diagnosis of follicular variant of papillary thyroid carcinoma. Am J Surg Pathol 2004;28:1336-1340.
4. Elsheikh TM, Asa SL, Chan JK, et al. Interobserver and intraobserver variation among experts in the diagnosis of thyroid follicular lesions with borderline nuclear features of papillary carcinoma. Am J Clin Pathol 2008;130:736-744.
5. Adeniran AJ, Zhu Z, Gandhi M, et al. Correlation between genetic alterations and microscopic features, clinical manifestations, and prognostic characteristics of thyroid papillary carcinomas. Am J Surg Pathol 2006;30:216-222.
6. Lang W, Choritz H, Hundeshagen H. Risk factors in follicular thyroid carcinomas. A retrospective followup study covering a 14-year period with emphasis on morphological findings. Am J Surg Pathol 1986;10:246-255.
7. Ricarte-Filho JCM, Ryder M, Chitale DA, et al. Mutational profile of advanced primary and metastatic radioactive iodine-refractory thyroid cancers reveals distinct pathogenetic roles for BRAF, PIK3CA and AKT1. Cancer Res 2009;69:4885-4893.
8. Imkamp F, von Wasielewski R, Musholt TJ, et al. Rearrangement analysis in archival thyroid tissues: transcripts. J Surg Res 2007;143:350-363.
9. Nikiforova MN, Biddinger PW, Caudill CM, et al. PAX8-PPARgamma rearrangement in thyroid tumors: RT-PCR and immunohistochemical analyses. Am J Surg Pathol 2002;26:1016-1023.
10. Nikiforova MN, Lynch RA, Biddinger PW, et al. RAS point mutations and PAX8-PPARgamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma. J Clin Endocrinol Metab 2003;88:2318-2326.
11. Lemoine NR, Mayall ES, Wyllie FS, et al. High frequency of ras oncogene activation in all stages of human thyroid tumorigenesis. Oncogene 1989;4:159-164.
12. Suarez HG, du Villard JA, Severino M, et al. Presence of mutations in all three ras genes in human thyroid tumors. Oncogene 1990;5:565-570.
13. Esapa CT, Johnson SJ, Kendall-Taylor P, et al. Prevalence of Ras mutations in thyroid neoplasia. Clin Endocrinol (Oxf) 1999;50:529-535.
14. Motoi N, Sakamoto A, Yamochi T, et al. Role of ras mutation in the progression of thyroid carcinoma of follicular epithelial origin. Pathol Res Pract 2000;196:1-7.
15. Namba H, Rubin SA, Fagin JA. Point mutations of ras oncogenes are an early event in thyroid tumorigenesis. Mol Endocrinol 1990;4:1474-1479.
16. Castro P, Rebocho AP, Soares RJ, et al. PAX8-PPARgamma rearrangement is frequently detected in the follicular variant of papillary thyroid carcinoma. J Clin Endocrinol Metab 2006;91:213-220.
17. Zhu Z, Gandhi M, Nikiforova MN, et al. Molecular profile and clinical-pathologic features of the follicular variant of papillary thyroid carcinoma. An unusually high prevalence of ras mutations. Am J Clin Pathol 2003;120:71-77.
18. Nikiforov YE. Thyroid carcinoma: molecular pathways and therapeutic targets. Mod Pathol 2008;21(Suppl 2): S37-S43.
19. Nikiforova MN, Biddinger PW, Caudill CM, et al. PAX8-PPARgamma rearrangement in thyroid tumors: RT-PCR and immunohistochemical analyses. Am J Surg Pathol 2002;26:1016-1023.
20. Marques AR, Espadinha C, Catarino AL, et al. Expression of PAX8-PPARgamma 1 rearrangements in both follicular thyroid carcinomas and adenomas. J Clin Endocrinol Metab 2002;87:3947-3952.
21. French CA, Alexander EK, Cibas ES, et al. Genetic and biologic subgroups of early stage follicular thyroid cancer. Am J Pathol 2003;162:1053-1060.
22. Passler C, Prager G, Scheuba C, et al. Follicular variant of papillary thyroid carcinoma: a long-term follow-up. Arch Surg 2003;138:1362-1366.
23. Baloch ZW, LiVolsi VA. Encapsulated follicular variant of papillary thyroid carcinoma with bone metastases. Mod Pathol 2000;13:861-865.
24. Rivera M, Tuttle RM, Patel S, et al. Encapsulated papillary thyroid carcinoma: a clinico-pathologic study of 106 cases with emphasis on its morphologic subtypes (histologic growth pattern). Thyroid 2009;19: 119-127.
25. Rivera M, Ricarte-Filho J, Knauf J, et al. Molecular and morphologic characterization of thyroid carcinomas according to extra-thyroid extension status. Mod Pathol 2010;23(Suppl 1S):132A (Abst 584).